This antibody is intended for in vitro diagnostic (IVD) use.
Ventana Medical Systems' (Ventana) CONFIRM anti-LMO2 (1A9-1) Mouse Monoclonal Primary Antibody is designed to qualitatively detect the presence of LMO2 expressing cells via light microscopy in formalin-fixed, paraffin-embedded tissue. Positive staining results may aid in the classification of B-cell lymphomas. The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests.